Genetics of amyotrophic lateral sclerosis: An update

Molecular Neurodegeneration

Volumn 8, Issue 1, 2013, Pages

  Chen, Sheng ^a,b   Sayana, Pavani ^b   Zhang, Xiaojie ^a   Le, Weidong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Amyotrophic lateral sclerosis; Apoptosis; Autophagy; Disease related gene mutations; Glutamate excitotoxicity; Oxidative stress

Indexed keywords

ALSIN; ANGIOGENIN; APURINIC ENDONUCLEASE 1; ARYLDIALKYLPHOSPHATASE; ATAXIN 1; ATAXIN 2; CHARGED MULTIVESICULAR BODY PROTEIN 2B; COPPER ZINC SUPEROXIDE DISMUTASE; DYNACTIN; ENDONUCLEASE; FIG 4 PROTEIN; FTD1 PROTEIN; FTD2 PROTEIN; FUSED IN SARCOMA PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; OPTINEURIN; PERIPHERIN; PROGRANULIN; PROTEIN; SENATAXIN; SIGMAR1 PROTEIN; SPATACSIN; SURVIVAL MOTOR NEURON PROTEIN 1; SURVIVAL MOTOR NEURON PROTEIN 2; SYNAPTOBREVIN; TAR DNA BINDING PROTEIN; UBIQUILIN 2; UNCLASSIFIED DRUG; VALOSIN CONTAINING PROTEIN; VASCULOTROPIN; VESICLE ASSOCIATED MEMBRANE PROTEIN ASSOCIATED PROTEIN B;

AMYOTROPHIC LATERAL SCLEROSIS; GENE MAPPING; GENETIC LINKAGE; GENETICS; HUMAN; INDEL MUTATION; INHERITANCE; MISSENSE MUTATION; MOTONEURON; NEUROFILAMENT; NEUROPATHOLOGY; NONHUMAN; NONSENSE MUTATION; REVIEW;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; HUMANS;

EID: 84881275424     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-8-28     Document Type: Review

References (117)

1. The microglial-motoneuron dialogue in ALS. Appel SH, Zhao W, Beers DR, Henkel JS, Acta Myol 2011 30 4 8 21842586
2. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Pasinelli P, Brown RH, Nat Rev Neurosci 2006 7 710 723 16924260 (Pubitemid 44267495)
3. Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing? Czaplinski A, Yen AA, Simpson EP, Appel SH, Arch Neurol 2006 63 1139 1143 10.1001/archneur.63.8.1139 16908741 (Pubitemid 44232321)
4. Mutations of optineurin in amyotrophic lateral sclerosis. Maruyama H, Morino H, Ito H, Izumi Y, Kato H, Watanabe Y, Kinoshita Y, Kamada M, Nodera H, Suzuki H, Komure O, Matsuura S, Kobatake K, Morimoto N, Abe K, Suzuki N, Aoki M, Kawata A, Hirai T, Kato T, Ogasawara K, Hirano A, Takumi T, Kusaka H, Hagiwara K, Kaji R, Kawakami H, Nature 2010 465 223 226 10.1038/nature08971 20428114
5. Controversies and priorities in amyotrophic lateral sclerosis. Turner MR, Hardiman O, Benatar M, Brooks BR, Chio A, de Carvalho M, Ince PG, Lin C, Miller RG, Mitsumoto H, Nicholson G, Ravits J, Shaw PJ, Swash M, Talbot K, Traynor BJ, Van den Berg LH, Veldink JH, Vucic S, Kiernan MC, Lancet Neurol 2013 12 310 322 10.1016/S1474-4422(13)70036-X 23415570
6. A rare Cu/Zn superoxide dismutase mutation causing familial amyotrophic lateral sclerosis with variable age of onset, incomplete penetrance and a sensory neuropathy. Rezania K, Yan J, Dellefave L, Deng HX, Siddique N, Pascuzzi RT, Siddique T, Roos RP, Amyotroph Lateral Scler Other Motor Neuron Disord 2003 4 162 166 10.1080/aml.4.3.162.166 13129803 (Pubitemid 37184885)
7. Familial ALS with extreme phenotypic variability due to the I113T SOD1 mutation. Lopate G, Baloh RH, Al-Lozi MT, Miller TM, Fernandes Filho JA, Ni O, Leston A, Florence J, Schierbecker J, Allred P, Amyotroph Lateral Scler 2010 11 232 236 10.3109/17482960902898069 20184521
8. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Mackenzie IR, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, Kwong LK, Forman MS, Ravits J, Stewart H, Eisen A, McClusky L, Kretzschmar HA, Monoranu CM, Highley JR, Kirby J, Siddique T, Shaw PJ, Lee VM, Trojanowski JQ, Ann Neurol 2007 61 427 434 10.1002/ana.21147 17469116 (Pubitemid 46878770)
9. The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies. Gurney ME, J Neurol Sci 1997 152 Suppl 1 67 S73 9419057
10. Copper-zinc superoxide dismutase-deficient mice show increased susceptibility to experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein 35-55. Massilamany C, Gangaplara A, Kim H, Stanford C, Rathnaiah G, Steffen D, Lee J, Reddy J, J Neuroimmunol 2013 256 19 27 10.1016/j.jneuroim.2012.12.004 23294897
11. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Hadano S, Hand CK, Osuga H, Yanagisawa Y, Otomo A, Devon RS, Miyamoto N, Showguchi-Miyata J, Okada Y, Singaraja R, Figlewicz DA, Kwiatkowski T, Hosler BA, Sagie T, Skaug J, Nasir J, Brown RH Jr, Scherer SW, Rouleau GA, Hayden MR, Ikeda JE, Nature Genet 2001 29 166 173 10.1038/ng1001-166 11586298 (Pubitemid 32952653)
12. Alsin, the product of ALS2 gene, suppresses SOD1 mutant neurotoxicity through RhoGEF domain by interacting with SOD1 mutants. Kanekura K, Hashimoto Y, Niikura T, Aiso S, Matsuoka M, Nishimoto I, J Biol Chem 2004 279 19247 19256 10.1074/jbc.M313236200 14970233 (Pubitemid 38623356)
13. Alsin and SOD1(G93A) proteins regulate endosomal reactive oxygen species production by glial cells and proinflammatory pathways responsible for neurotoxicity. Li Q, Spencer NY, Pantazis NJ, Engelhardt JF, J Biol Chem 2011 286 40151 40162 10.1074/jbc.M111.279711 21937428
14. ALS2/alsin deficiency in neurons leads to mild defects in macropinocytosis and axonal growth. Otomo A, Kunita R, Suzuki-Utsunomiya K, Mizumura H, Onoe K, Osuga H, Hadano S, Ikeda JE, Biochem Biophys Res Commun 2008 370 87 92 10.1016/j.bbrc.2008.01.177 18358238
15. ALS2/alsin knockout mice and motor neuron diseases. Cai H, Shim H, Lai C, Xie C, Lin X, Yang WJ, Chandran J, Neurodegener Dis 2008 5 359 366 10.1159/000151295 18714162
16. Als2 mRNA splicing variants detected in KO mice rescue severe motor dysfunction phenotype in Als2 knock-down zebrafish. Gros-Louis F, Kriz J, Kabashi E, McDearmid J, Millecamps S, Urushitani M, Lin L, Dion P, Zhu Q, Drapeau P, Julien JP, Rouleau GA, Hum Mol Genet 2008 17 2691 2702 10.1093/hmg/ddn171 18558633
17. Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34. Chance PF, Rabin BA, Ryan SG, Ding Y, Scavina M, Crain B, Griffin JW, Cornblath DR, Am J Hum Genet 1998 62 633 640 10.1086/301769 9497266 (Pubitemid 28164621)
18. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Chen Y-Z, Bennett CL, Huynh HM, Blair IP, Puls I, Irobi J, Dierick I, Abel A, Kennerson ML, Rabin BA, Nicholson GA, Auer-Grumbach M, Wagner K, De Jonghe P, Griffin JW, Fischbeck KH, Timmerman V, Cornblath DR, Chance PF, Am J Hum Genet 2004 74 1128 1135 10.1086/421054 15106121 (Pubitemid 38669312)
19. Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2. Moreira M-C, Klur S, Watanabe M, Nemeth AH, Le Ber I, Moniz J-C, Tranchant C, Aubourg P, Tazir M, Schöls L, Pandolfo P, Schulz JB, Pouget J, Calvas P, Shizuka-Ikeda M, Shoji M, Tanaka M, Izatt L, Shaw CE, M'Zahem A, Dunne E, Bomont P, Benhassine T, Bouslam N, Stevanin G, Brice A, Guimarães J, Mendonça P, Barbot C, Coutinho P, Sequeiros J, Dürr A, Warter JM, Koenig M, Nature Genet. 2004 36 225 227 10.1038/ng1303 14770181 (Pubitemid 38282744)
20. Mutations in the gene encoding immunoglobulin mu- binding protein 2 cause spinal muscular atrophy with respiratory distress type 1. Grohmann K, Schuelke M, Diers A, Hoffmann K, Lucke B, Adams C, Bertini E, Leonhardt-Horti H, Muntoni F, Ouvrier R, Pfeufer A, Rossi R, Van Maldergem L, Wilmshurst JM, Wienker TF, Sendtner M, Rudnik-Schöneborn S, Zerres K, Hübner C, Nat Genet 2001 29 75 77 10.1038/ng703 11528396 (Pubitemid 32801813)
21. Human senataxin resolves RNA/DNA hybrids formed at transcriptional pause sites to promote Xrn2-dependent termination. Skourti-Stathaki K, Proudfoot NJ, Gromak N, Mol Cell 2011 42 794 805 10.1016/j.molcel.2011.04.026 21700224
22. Linkage of a commoner form of recessive amyotrophic lateral sclerosis to chromosome 15q15-q22 markers. Hentati A, Ouahchi K, Pericak-Vance MA, Nijhawan D, Ahmad A, Yang Y, Rimmler J, Hung W, Schlotter B, Ahmed A, Ben Hamida M, Hentati F, Siddique T, Neurogenetics 1998 2 55 60 10.1007/s100480050052 9933301 (Pubitemid 29067535)
23. Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. Stevanin G, Santorelli FM, Azzedine H, Coutinho P, Chomilier J, Denora PS, Martin E, Ouvrard-Hernandez AM, Tessa A, Bouslam N, Lossos A, Charles P, Loureiro JL, Elleuch N, Confavreux C, Cruz VT, Ruberg M, Leguern E, Grid D, Tazir M, Fontaine B, Filla A, Bertini E, Durr A, Brice A, Nat Genet 2007 39 366 372 10.1038/ng1980 17322883 (Pubitemid 46328495)
24. SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Orlacchio A, Babalini C, Borreca A, Patrono C, Massa R, Basaran S, Munhoz RP, Rogaeva EA, St George-Hyslop PH, Bernardi G, Kawarai T, Brain 2010 133 591 598 10.1093/brain/awp325 20110243
25. Cellular distribution and subcellular localization of spatacsin and spastizin, two proteins involved in hereditary spastic paraplegia. Murmu RP, Martin E, Rastetter A, Esteves T, Muriel MP, El Hachimi KH, Denora PS, Dauphin A, Fernandez JC, Duyckaerts C, Brice A, Darios F, Stevanin G, Mol Cell Neurosci 2011 47 191 202 10.1016/j.mcn.2011.04.004 21545838
26. Identification of two novel loci for dominantly inherited familial amyotrophic lateral sclerosis. Sapp PC, Hosler BA, McKenna-Yasek D, Chin W, Gann A, Genise H, Gorenstein J, Huang M, Sailer W, Scheffler M, Valesky M, Haines JL, Pericak-Vance M, Siddique T, Horvitz HR, Brown RH Jr, Am J Hum Genet 2003 73 397 403 10.1086/377158 12858291 (Pubitemid 36921002)
27. FUS-related proteinopathies: lessons from animal models. Lanson NA Jr, Pandey UB, Brain Res 2012 1462 3 15 22444279
28. Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations. Bäumer D, Hilton D, Paine SM, Turner MR, Lowe J, Talbot K, Ansorge O, Neurology 2010 75 611 618 10.1212/WNL.0b013e3181ed9cde 20668261
29. The RNA-binding protein FUS/TLS is a common aggregate-interacting protein in polyglutamine diseases. Doi H, Koyano S, Suzuki Y, Nukina N, Kuroiwa Y, Neurosci Res 2010 66 131 133 10.1016/j.neures.2009.10.004 19833157
30. ALS-associated fused in sarcoma (FUS) mutations disrupt transportin-mediated nuclear import. Dormann D, Rodde R, Edbauer D, Bentmann E, Fischer I, Hruscha A, Than ME, Mackenzie IR, Capell A, Schmid B, Neumann M, Haass C, EMBO J 2010 29 2841 2857 10.1038/emboj.2010.143 20606625
31. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Bosco DA, Lemay N, Ko HK, Zhou H, Burke C, Kwiatkowski TJ Jr, Sapp P, McKenna-Yasek D, Brown RH Jr, Hayward LJ, Hum Mol Genet 2010 19 4160 4175 10.1093/hmg/ddq335 20699327
32. FUS transgenic rats develop the phenotypes of amyotropic lateral sclerosis and frontotemporal lobar degeneration. Haung C, Zhou H, Tong J, Chen H, Liu YJ, Wang D, Wei X, Xia XG, PLoS Genet 2011 7 100
33. Expression of human FUS protein in Drosophila leads to progressive neurodegeneration. Chen Y, Yang M, Deng J, Chen X, Ye Y, Zhu L, Liu J, Ye H, Shen Y, Li Y, Rao EJ, Fushimi K, Zhou X, Bigio EH, Mesulam M, Xu Q, Wu JY, Protein Cell 2011 2 477 486 10.1007/s13238-011-1065-7 21748598
34. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Nishimura AL, Mitne-Neto M, Silva HC, Richieri-Costa A, Middleton S, Cascio D, Kok F, Oliveira JR, Gillingwater T, Webb J, Skehel P, Zatz M, Am J Hum Genet 2004 75 822 831 10.1086/425287 15372378 (Pubitemid 39390489)
35. Characterization of the properties of a novel mutation in VAPB in familial amyotrophic lateral sclerosis. Chen HJ, Anagnostou G, Chai A, Withers J, Morris A, Adhikaree J, Pennetta G, de Belleroche JS, J Biol Chem 2010 285 40266 40281 10.1074/jbc.M110.161398 20940299
36. Motor neuron disease-associated mutant vesicle-associated membrane protein-associated protein (VAP) B recruits wild-type VAPs into endoplasmic reticulum-derived tubular aggregates. Teuling E, Ahmed S, Haasdijk E, Demmers J, Steinmetz MO, Akhmanova A, Jaarsma D, Hoogenraad CC, J Neurosci 2007 27 9801 9815 10.1523/JNEUROSCI.2661-07.2007 17804640 (Pubitemid 47492194)
37. Amyotrophic lateral sclerosis mutant vesicle-associated membrane protein-associated protein-B transgenic mice develop TAR-DNA-binding protein-43 pathology. Tudor EL, Galtrey CM, Perkinton MS, Lau KF, De Vos KJ, Mitchell JC, Ackerley S, Hortobágyi T, Vámos E, Leigh PN, Klasen C, McLoughlin DM, Shaw CE, Miller CC, Neuroscience 2010 167 774 785 10.1016/j.neuroscience. 2010.02.035 20188146
38. VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis. De Vos KJ, Mórotz GM, Stoica R, Tudor EL, Lau KF, Ackerley S, Warley A, Shaw CE, Miller CC, Hum Mol Genet 2012 21 1299 1311 10.1093/hmg/ddr559 22131369
39. Widespread aggregation of mutant VAPB associated with ALS does not cause motor neuron degeneration or modulate mutant SOD1 aggregation and toxicity in mice. Qiu L, Qiao T, Beers M, Tan W, Wang H, Yang B, Xu Z, Mol Neurodegener 2013 8 1 10.1186/1750-1326-8-1 23281774
40. A novel candidate region for ALS on chromosome 14q11.2. Greenway MJ, Alexander MD, Ennis S, Traynor BJ, Corr B, Frost E, Green A, Hardiman O, Neurology 2004 63 1936 1938 10.1212/01.WNL.0000144344.39103.F6 15557516 (Pubitemid 39532395)
41. Variations in the coding and regulatory sequences of the angiogenin (ANG) gene are not associated to ALS (amyotrophic lateral sclerosis) in the Italian population. Corrado L, Battistini S, Penco S, Bergamaschi L, Testa L, Ricci C, Giannini F, Greco G, Patrosso MC, Pileggi S, Causarano R, Mazzini L, Momigliano-Richiardi P, D'Alfonso S, J Neurol Sci 2007 258 123 127 10.1016/j.jns.2007.03.009 17462671 (Pubitemid 46876738)
42. SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. Millecamps S, Salachas F, Cazeneuve C, Gordon P, Bricka B, Camuzat A, Guillot-Noël L, Russaouen O, Bruneteau G, Pradat PF, Le Forestier N, Vandenberghe N, Danel-Brunaud V, Guy N, Thauvin-Robinet C, Lacomblez L, Couratier P, Hannequin D, Seilhean D, Le Ber I, Corcia P, Camu W, Brice A, Rouleau G, LeGuern E, Meininger V, J Med Genet 2010 47 554 560 10.1136/jmg.2010.077180 20577002
43. SOD1 G93D sporadic amyotrophic lateral sclerosis (SALS) patient with rapid progression and concomitant novel ANG variant. Luigetti M, Lattante S, Zollino M, Conte A, Marangi G, Del Grande A, Sabatelli M, Neurobiol Aging 1924 2011 32
44. Mechanisms of loss of functions of human angiogenin variants implicated in amyotrophic lateral sclerosis. Padhi AK, Kumar H, Vasaikar SV, Jayaram B, Gomes J, PLoS One 2012 7 32479 10.1371/journal.pone.0032479 22384259
45. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, Ackerley S, Durnall JC, Williams KL, Buratti E, Baralle F, de Belleroche J, Mitchell JD, Leigh PN, Al-Chalabi A, Miller CC, Nicholson G, Shaw CE, Science 2008 319 1668 1672 10.1126/science.1154584 18309045 (Pubitemid 351432505)
46. Understanding the role of TDP-43 and FUS/TLS in ALS and beyond. Da Cruz S, Cleveland DW, Curr Opin Neurobiol 2011 21 904 919 10.1016/j.conb.2011.05.029 21813273
47. The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation. Buratti E, Baralle FE, RNA Biol 2010 7 420 429 10.4161/rna.7.4.12205 20639693
48. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, Ling SC, Sun E, Wancewicz E, Mazur C, Kordasiewicz H, Sedaghat Y, Donohue JP, Shiue L, Bennett CF, Yeo GW, Cleveland DW, Nat Neurosci 2011 14 459 468 10.1038/nn.2779 21358643
49. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Tollervey JR, Curk T, Rogelj B, Briese M, Cereda M, Kayikci M, König J, Hortobágyi T, Nishimura AL, Zupunski V, Patani R, Chandran S, Rot G, Zupan B, Shaw CE, Ule J, Nat Neurosci 2011 14 452 458 10.1038/nn.2778 21358640
50. TDP-43 physically interacts with amyotrophic lateral sclerosis-linked mutant CuZn superoxidedismutase. Higashi S, Tsuchiya Y, Araki T, Wada K, Kabuta T, Neurochem Int 2010 57 906 913 10.1016/j.neuint.2010.09.010 20933032
51. Rodent models of TDP-43: recent advances. Tsao W, Jeong YH, Lin S, Ling J, Price DL, Chiang PM, Wong PC, Brain Res 2012 1462 26 39 22608070
52. Rodent models of TDP-43 proteinopathy: investigating the mechanisms of TDP-43-mediated neurodegeneration. Gendron TF, Petrucelli L, J Mol Neurosci 2011 45 486 499 10.1007/s12031-011-9610-7 21811811
53. Does a loss of TDP-43 function cause neurodegeneration? Xu ZS, Mol Neurodegener 2012 7 27 10.1186/1750-1326-7-27 22697423
54. SOD1 and TDP- 43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments. Joyce PI, Fratta P, Fisher EM, Acevedo-Arozena A, Mamm Genome 2011 22 420 448 10.1007/s00335-011-9339-1 21706386
55. Mutation of FIG 4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J. Chow CY, Zhang Y, Dowling JJ, Jin N, Adamska M, Shiga K, Szigeti K, Shy ME, Li J, Zhang X, Lupski JR, Weisman LS, Meisler MH, Nature 2007 448 68 72 10.1038/nature05876 17572665 (Pubitemid 47036999)
56. A protein complex that regulates PtdIns(3,5)P2 levels. Michell RH, Dove SK, EMBO J 2009 28 86 97 10.1038/emboj.2008.270 19158662
57. Loss of Vac14, a regulator of the signaling lipid phosphatidylinositol 3,5-biphosphate, results in neurodegeneration in mice. Zhang Y, Zolov SN, Chow CY, Slutsky SG, Richardson SC, Piper RC, Yang B, Nau JJ, Westrick RJ, Morrison SJ, Meisler MH, Weisman LS, Proc Natl Acad Sci USA 2007 104 17518 17523 10.1073/pnas.0702275104 17956977 (Pubitemid 350219870)
58. Optineurin with amyotrophic lateral sclerosis-related mutations abrogates inhibition of interferon regulatory factor-3 activation. Sakaguchi T, Irie T, Kawabata R, Yoshida A, Maruyama H, Kawakami H, Neurosci Lett 2011 505 279 281 10.1016/j.neulet.2011.10.040 22040667
59. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Wild P, Farhan H, McEwan DG, Wagner S, Rogov VV, Brady NR, Richter B, Korac J, Waidmann O, Choudhary C, Dötsch V, Bumann D, Dikic I, Science 2011 333 228 233 10.1126/science.1205405 21617041
60. Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates. Korac J, Schaeffer V, Kovacevic I, Clement AM, Jungblut B, Behl C, Terzic J, Dikic I, J Cell Sci 2013 126 580 592 10.1242/jcs.114926 23178947
61. Exome sequencing reveals VCP mutations as a cause of familial ALS. Johnson JO, Mandrioli J, Benatar M, Abramzon Y, Van Deerlin VM, Trojanowski JQ, Gibbs JR, Brunetti M, Gronka S, Wuu J, Ding J, McCluskey L, Martinez-Lage M, Falcone D, Hernandez DG, Arepalli S, Chong S, Schymick JC, Rothstein J, Landi F, Wang YD, Calvo A, Mora G, Sabatelli M, Monsurrò MR, Battistini S, Salvi F, Spataro R, Sola P, Borghero G, Consortium ITALSGEN, Galassi G, Scholz SW, Taylor JP, Restagno G, Chiò A, Traynor BJ, Neuron 2010 68 857 864 10.1016/j.neuron.2010.11.036 21145000
62. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. Weihl CC, Temiz P, Miller SE, Watts G, Smith C, Forman M, Hanson PI, Kimonis V, Pestronk A, J Neurol Neurosurg Psychiatry 2008 79 1186 1189 10.1136/jnnp.2007.131334 18796596
63. Increased expression of valosin-containing protein in the skin of patients with amyotrophic lateral sclerosis. Ishikawa H, Yasui K, Oketa Y, Suzuki M, Ono S, J Clin Neurosci 2012 19 522 526 10.1016/j.jocn.2011.05.044 22321369
64. Assignment of ubiquilin2 (UBQLN2) to human chromosome xp11: 23- > p11.1 by Gene Bridge radiation hybrids. Kaye FJ, Shows TB, Cytogenet Cell Genet 2000 89 116 117 10.1159/000015588 10894951 (Pubitemid 30435272)
65. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Deng H-X, Chen W, Hong S-T, Boycott KM, Gorrie GH, Siddique N, Yang Y, Fecto F, Shi Y, Zhai H, Jiang H, Hirano M, Rampersaud E, Jansen GH, Donkervoort S, Bigio EH, Brooks BR, Ajroud K, Sufit RL, Haines JL, Mugnaini E, Pericak-Vance MA, Siddique T, Nature 2011 477 211 215 10.1038/nature10353 21857683
66. Motor neuron disease: a role for ubiquilin 2 mutations in neurodegeneration. Daoud H, Rouleau GA, Nat Rev Neurol 2011 7 599 600 10.1038/nrneurol.2011.163 21989241
67. A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Al-Saif A, Al-Mohanna F, Bohlega S, Ann Neurol 2011 70 913 919 10.1002/ana.22534 21842496
68. A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Morita M, Al-Chalabi A, Andersen PM, Hosler B, Sapp P, Englund E, Mitchell JE, Habgood JJ, de Belleroche J, Xi J, Jongjaroenprasert W, Horvitz HR, Gunnarsson LG, Brown RH Jr, Neurology 2006 66 839 844 10.1212/01.wnl. 0000200048.53766.b4 16421333 (Pubitemid 43739757)
69. Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease. Luty AA, Kwok JB, Dobson-Stone C, Loy CT, Coupland KG, Karlström H, Sobow T, Tchorzewska J, Maruszak A, Barcikowska M, Panegyres PK, Zekanowski C, Brooks WS, Williams KL, Blair IP, Mather KA, Sachdev PS, Halliday GM, Schofield PR, Ann Neurol 2010 68 639 649 10.1002/ana.22274 21031579
70. Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22. Hosler BA, Siddique T, Sapp PC, Sailor W, Huang MC, Hossain A, Daube JR, Nance M, Fan C, Kaplan J, Hung WY, McKenna-Yasek D, Haines JL, Pericak-Vance MA, Horvitz HR, Brown RH Jr, JAMA 2000 284 1664 1669 10.1001/jama.284.13.1664 11015796
71. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, Kouri N, Wojtas A, Sengdy P, Hsiung GY, Karydas A, Seeley WW, Josephs KA, Coppola G, Geschwind DH, Wszolek ZK, Feldman H, Knopman DS, Petersen RC, Miller BL, Dickson DW, Boylan KB, Graff-Radford NR, Rademakers R, Neuron 2011 72 245 256 10.1016/j.neuron.2011.09.011 21944778
72. How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders? van Blitterswijk M, DeJesus-Hernandez M, Rademakers R, Curr Opin Neurol 2012 25 689 700 10.1097/WCO.0b013e32835a3efb 23160421
73. Advances in understanding the molecular basis of frontotemporal dementia. Rademakers R, Neumann M, Mackenzie IR, Nat Rev Neurol 2012 8 423 434 22732773
74. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Mori K, Weng SM, Arzberger T, May S, Rentzsch K, Kremmer E, Schmid B, Kretzschmar HA, Cruts M, Van Broeckhoven C, Haass C, Edbauer D, Science 2013 339 1335 1338 10.1126/science.1232927 23393093
75. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Ash PE, Bieniek KF, Gendron TF, Caulfield T, Lin WL, Dejesus-Hernandez M, van Blitterswijk MM, Jansen-West K, Paul JW 3rd, Rademakers R, Boylan KB, Dickson DW, Petrucelli L, Neuron 2013 77 639 646 10.1016/j.neuron.2013.02.004 23415312
76. Misregulated RNA processing in amyotrophic lateral sclerosis. Polymenidou M, Lagier-Tourenne C, Hutt KR, Bennett CF, Cleveland DW, Yeo GW, Brain Res 2012 1462 3 15 22444279
77. Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Münch C, Sedlmeier R, Meyer T, Homberg V, Sperfeld AD, Kurt A, Prudlo J, Peraus G, Hanemann CO, Stumm G, Ludolph AC, Neurology 2004 63 724 726 10.1212/01.WNL.0000134608.83927.B1 15326253 (Pubitemid 39100836)
78. Localization of the DCTN1 gene encoding p150 (Glued) to human chromosome 2p13 by fluorescence in situ hybridization. Holzbaur ELF, Tokito MK, Genomics 1996 31 398 399 10.1006/geno.1996.0068 8838327
79. The G59S mutation in p150(glued) causes dysfunction of dynactin in mice. Lai C, Lin X, Chandran J, Shim H, Yang WJ, Cai H, J Neurosci 2007 27 13982 13990 10.1523/JNEUROSCI.4226-07.2007 18094236 (Pubitemid 351377874)
80. Motor neuron disease occurring in a mutant dynactin mouse model is characterized by defects in vesicular trafficking. Laird FM, Farah MH, Ackerley S, Hoke A, Maragakis N, Rothstein JD, Griffin J, Price DL, Martin LJ, Wong PC, J Neurosci 2008 28 1997 2005 10.1523/JNEUROSCI.4231-07.2008 18305234 (Pubitemid 351317634)
81. Mutant dynactin in motor neuron disease. Puls I, Jonnakuty C, LaMonte BH, Holzbaur EL, Tokito M, Mann E, Floeter MK, Bidus K, Drayna D, Oh SJ, Brown RH Jr, Ludlow CL, Fischbeck KH, Nat Genet 2003 33 455 456 10.1038/ng1123 12627231 (Pubitemid 36390002)
82. Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase. Mitchell J, Paul P, Chen HJ, Morris A, Payling M, Falchi M, Habgood J, Panoutsou S, Winkler S, Tisato V, Hajitou A, Smith B, Vance C, Shaw C, Mazarakis ND, de Belleroche J, Proc Natl Acad Sci USA 2010 107 7556 7561 10.1073/pnas.0914128107 20368421
83. The genetic and biochemical properties of the D-amino acid oxidases in human tissues. Barker RF, Hopkinson DA, Ann Hum Genet 1977 41 27 42 10.1111/j.1469-1809.1977.tb01959.x 21608 (Pubitemid 8149633)
84. D-amino acid oxidase controls motoneuron degeneration through D-serine. Sasabe J, Miyoshi Y, Suzuki M, Mita M, Konno R, Matsuoka M, Hamase K, Aiso S, Proc Natl Acad Sci USA 2012 109 627 632 10.1073/pnas.1114639109 22203986
85. Molecular genetic analysis of the APEX nuclease gene in amyotrophic lateral sclerosis. Hayward C, Colville S, Swingler RJ, Brock DJ, Neurology 1999 52 1899 1901 10.1212/WNL.52.9.1899 10371543 (Pubitemid 29260908)
86. Screening of AP endonuclease as a candidate gene for amyotrophic lateral sclerosis (ALS). Tomkins J, Dempster S, Banner SJ, Cookson MR, Shaw PJ, Neuroreport 2000 11 1695 1697 10.1097/00001756-200006050-00020 10852227 (Pubitemid 30350336)
87. The repair function of the multifunctional DNA repair/redox protein APE1 is neuroprotective after ionizing radiation. Vasko MR, Guo C, Thompson EL, Kelley MR, DNA Repair (Amst) 2011 10 942 952 10.1016/j.dnarep.2011.06.004
88. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Skibinski G, Parkinson NJ, Brown JM, Chakrabarti L, Lloyd SL, Hummerich H, Nielsen JE, Hodges JR, Spillantini MG, Thusgaard T, Brandner S, Brun A, Rossor MN, Gade A, Johannsen P, Sørensen SA, Gydesen S, Fisher EM, Collinge J, Nat Genet 2005 37 806 808 10.1038/ng1609 16041373 (Pubitemid 41077105)
89. Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS). Cox LE, Ferraiuolo L, Goodall EF, Heath PR, Higginbottom A, Mortiboys H, Hollinger HC, Hartley JA, Brockington A, Burness CE, Morrison KE, Wharton SB, Grierson AJ, Ince PG, Kirby J, Shaw PJ, PLoS One 2010 5 9872 10.1371/journal.pone.0009872 20352044
90. CHMP2B mutants linked to frontotemporal dementia impair maturation of dendritic spines. Belly A, Bodon G, Blot B, Bouron A, Sadoul R, Goldberg Y, J Cell Sci 2010 123 2943 2954 10.1242/jcs.068817 20699355
91. Progressive neuronal inclusion formation and axonal degeneration in CHMP2B mutant transgenic mice. Ghazi-Noori S, Froud KE, Mizielinska S, Powell C, Smidak M, Fernandez De Marco M, O'Malley C, Farmer M, Parkinson N, Fisher EM, Asante EA, Brandner S, Collinge J, Isaacs AM, Brian 2012 135 Pt 3 819 832
92. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Al-Chalabi A, Andersen PM, Nilsson P, Chioza B, Andersson JL, Russ C, Shaw CE, Powell JF, Leigh PN, Hum. Molec. Genet 1999 8 157 164 10.1093/hmg/8.2.157 9931323 (Pubitemid 29054257)
93. Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase. Couillard-Després S, Zhu Q, Wong PC, Price DL, Cleveland DW, Julien JP, Proc Natl Acad Sci USA 1998 95 9626 9630 10.1073/pnas.95.16.9626 9689131 (Pubitemid 28506282)
94. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Mersiyanova IV, Perepelov AV, Polyakov AV, Sitnikov VF, Dadali EL, Oparin RB, Petrin AN, Evgrafov OV, Am J Hum Gene 2000 67 37 46 10.1086/302962 (Pubitemid 30481542)
95. Analysis of heavy neurofilament subunit gene polymorphism in Russian patients with sporadic motor neuron disease (MND). Skvortsova V, Shadrina M, Slominsky P, Levitsky G, Kondratieva E, Zherebtsova A, Levitskaya N, Alekhin A, Serdyuk A, Limborska S, Eur J Hum Genet 2004 12 241 244 10.1038/sj.ejhg.5201144 14722583 (Pubitemid 38499984)
96. Paraoxonase 2 (PON2) in the mouse central nervous system: a neuroprotective role? Giordano G, Cole TB, Furlong CE, Costa LG, Toxicol Appl Pharmacol 2011 256 369 378 10.1016/j.taap.2011.02.014 21354197
97. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Horner RD, Kamins KG, Feussner JR, Grambow SC, Hoff-Lindquist J, Harati Y, Mitsumoto H, Pascuzzi R, Spencer PS, Tim R, Howard D, Smith TC, Ryan MA, Coffman CJ, Kasarskis EJ, Neurology 2003 61 742 749 10.1212/01.WNL.0000069922.32557.CA 14504315 (Pubitemid 37179883)
98. Paraoxonase cluster polymorphisms are associated with sporadic ALS. Saeed M, Siddique N, Hung WY, Usacheva E, Liu E, Sufit RL, Heller SL, Haines JL, Pericak-Vance M, Siddique T, Neurology 2006 67 771 776 10.1212/01.wnl. 0000227187.52002.88 16822964 (Pubitemid 44394187)
99. Association of paraoxonase gene cluster polymorphisms with ALS in France, Quebec, and Sweden. Valdmanis PN, Kabashi E, Dyck A, Hince P, Lee J, Dion P, D'Amour M, Souchon F, Bouchard JP, Salachas F, Meininger V, Andersen PM, Camu W, Dupré N, Rouleau GA, Neurology 2008 71 514 520 10.1212/01.wnl. 0000324997.21272.0c 18695162
100. Paraoxonase gene mutations in amyotrophic lateral sclerosis. Ticozzi N, LeClerc AL, Keagle PJ, Glass JD, Wills AM, van Blitterswijk M, Bosco DA, Rodriguez-Leyva I, Gellera C, Ratti A, Taroni F, McKenna-Yasek D, Sapp PC, Silani V, Furlong CE, Brown RH Jr, Landers JE, Ann Neurol 2010 68 102 107 10.1002/ana.21993 20582942
101. Peripherin partially localizes in Bunina bodies in amyotrophic lateral sclerosis. Mizuno Y, Fujita Y, Takatama M, Okamoto K, J Neurol Sci 2011 302 14 18 10.1016/j.jns.2010.12.023 21241994
102. Late onset of motor neurons in mice overexpressing wild-type peripherin. Beaulieu JM, Nguyen MD, Julien JP, J Cell Biol 1999 147 531 544 10.1083/jcb.147.3.531 15132161 (Pubitemid 29523460)
103. A novel peripherin gene (PRPH) mutation identified in one sporadic amyotrophic lateral sclerosis patient. Corrado L, Carlomagno Y, Falasco L, Mellone S, Godi M, Cova E, Cereda C, Testa L, Mazzini L, D'Alfonso S, Neurobiol Aging 2011 32 552 1 e6 21820212
104. A neurotoxic peripherin splice variant in a mouse model of ALS. Robertson J, Doroudchi MM, Nguyen MD, Durham HD, Strong MJ, Shaw G, Julien J-P, Mushynski WE, J Cell Biol 2003 160 939 949 10.1083/jcb.200205027 12642616 (Pubitemid 36350848)
105. Optineurin in Huntington's disease intranuclear inclusions. Schwab C, Yu S, McGeer EG, McGeer PL, Neurosci Lett 2012 506 149 154 10.1016/j.neulet.2011. 10.070 22085693
106. An aggregate-inducing peripherin isoform generated through intron retention is upregulated in amyotrophic lateral sclerosis and associated with disease pathology. Xiao S, Tjostheim S, Sanelli T, McLean JR, Horne P, Fan Y, Ravits J, Strong MJ, Robertson J, J Neurosci 2008 28 1833 1840 10.1523/JNEUROSCI.3222-07.2008 18287500 (Pubitemid 351302676)
107. Correlation between severity and SMN protein level in spinal muscular atrophy. Lefebvre S, Burlet P, Liu Q, Bertrandy S, Clermont O, Munnich A, Dreyfuss G, Melki J, Nat Genet 1997 16 265 269 10.1038/ng0797-265 9207792 (Pubitemid 27280210)
108. SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS. Veldink JH, Kalmijn S, Van der Hout AH, Lemmink HH, Groeneveld GJ, Lummen C, Scheffer H, Wokke JH, Van den Berg LH, Neurology 2005 65 820 825 10.1212/01.wnl.0000174472.03292.dd 16093455 (Pubitemid 41362123)
109. Amyotrophic Lateral Sclerosis.Abnormal SMN1 gene copy number is a susceptibility factor for amyotrophic lateral sclerosis. Corcia P, Mayeux-Portas V, Khoris J, de Toffol B, Autret A, Muh JP, Camu W, Andres C, French ALS Research Group, Ann Neurol 2002 51 243 246 10.1002/ana.10104 11835381 (Pubitemid 34111447)
110. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Oosthuyse B, Moons L, Storkebaum E, Beck H, Nuyens D, Brusselmans K, Van Dorpe J, Hellings P, Gorselink M, Heymans S, Theilmeier G, Dewerchin M, Laudenbach V, Vermylen P, Raat H, Acker T, Vleminckx V, Van Den Bosch L, Cashman N, Fujisawa H, Drost MR, Sciot R, Bruyninckx F, Hicklin DJ, Ince C, Gressens P, Lupu F, Plate KH, Robberecht W, Herbert JM, Collen D, Carmeliet P, Nat Genet 2001 28 131 138 10.1038/88842 11381259 (Pubitemid 32538057)
111. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Storkebaum E, Nat Neurosci 2005 8 85 92 10.1038/nn1360 15568021 (Pubitemid 41236736)
112. Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis. Brockington A, J Neuropathol Exp Neurol 2006 65 26 36 10.1097/01.jnen.0000196134.51217.74 16410746
113. Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the -2578AA genotype. Lambrechts D, Poesen K, Fernández-Santiago R, Al-Chalabi A, Del Bo R, Van Vught PW, Khan S, Marklund SL, Brockington A, van Marion I, Anneser J, Shaw C, Ludolph AC, Leigh NP, Comi GP, Gasser T, Shaw PJ, Morrison KE, Andersen PM, Van den Berg LH, Thijs V, Siddique T, Robberecht W, Carmeliet P, J Med Genet 2009 46 840 846 10.1136/jmg.2008.058222 18413368
114. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J, Sadovnick AD, Rollinson S, Cannon A, Dwosh E, Neary D, Melquist S, Richardson A, Dickson D, Berger Z, Eriksen J, Robinson T, Zehr C, Dickey CA, Crook R, McGowan E, Mann D, Boeve B, Feldman H, Hutton M, Nature 2006 442 916 919 10.1038/nature05016 16862116 (Pubitemid 44285946)
115. Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes. Schymick JC, Yang Y, Andersen PM, Vonsattel JP, Greenway M, Momeni P, Elder J, Chiò A, Restagno G, Robberecht W, Dahlberg C, Mukherjee O, Goate A, Graff-Radford N, Caselli RJ, Hutton M, Gass J, Cannon A, Rademakers R, Singleton AB, Hardiman O, Rothstein J, Hardy J, Traynor BJ, J Neurol Neurosurg Psychiatry 2007 78 754 756 17371905 (Pubitemid 46998853)
116. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, Armakola M, Geser F, Greene R, Lu MM, Padmanabhan A, Clay-Falcone D, McCluskey L, Elman L, Juhr D, Gruber PJ, Rüb U, Auburger G, Trojanowski JQ, Lee VM, Van Deerlin VM, Bonini NM, Gitler AD, Nature 2010 466 1069 1075 10.1038/nature09320 20740007
117. Ataxin-2 and huntingtin interact with endophilin-A complexes to function in plastin-associated pathways. Ralser M, Nonhoff U, Albrecht M, Lengauer T, Wanker EE, Lehrach H, Krobitsch S, Hum Molec Genet 2005 14 2893 2909 10.1093/hmg/ddi321 16115810 (Pubitemid 41418794)